Impact of Endothelial Dysfunction on Residual Platelet Aggregability after Dual Anti-platelet Therapy with Aspirin and Clopidogrel in Stable Patients with Coronary Artery Disease
Not Applicable
- Conditions
- coronary artery disease
- Registration Number
- JPRN-UMIN000008239
- Lead Sponsor
- Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1:acute coronary syndromes 2:known allergy to clopidogrel 3:thrombocytopenia 4:patients with collagen disease 5:infection 6:severe liver dysfunction 7:malignant diseases 8:patients were treated with ticlopidine, cilostazol and sarpogrelate 9:hemodialysis
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method endothelial function and residual platelet aggregability
- Secondary Outcome Measures
Name Time Method